Related Experiment Video
Updated: May 29, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Colonization of returning travelers with CTX-M-producing Escherichia coli
Gisele Peirano1, Kevin B Laupland, Daniel B Gregson
1Division of Microbiology, Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada.
Background:
We previously identified foreign travel as a risk factor for acquiring infections due to CTX-M (active on cefotaxime first isolated in Munich) producing Escherichia coli. The objective of this study was to assess the prevalence of extended-spectrum β-lactamase (ESBL)-producing E coli among stool samples submitted from travelers as compared to non-travelers (a non-traveler had not been outside of Canada for at least 6 months before submitting a stool specimen).
Methods:
Once a travel case was identified, the next stool from a non-traveler (not been outside of Canada for at least 6 months) was included and cultured on the chromID-ESBL selection media. Molecular characterization was done using polymerase chain reaction and sequencing for bla(CTX-Ms), bla(TEMs), bla(SHVs), plasmid-mediated quinolone-resistant determinants, O25-ST131, phylogenetic groups, pulsed-field gel electrophoresis (PFGE), and multilocus sequencing typing.
Results:
A total of 226 individuals were included; 195 (86%) were negative, and 31 (14%) were positive for ESBL-producing E coli. Notably, travelers were 5.2 (95% CI 2.1-31.1) times more likely than non-travelers to have an ESBL-producing E coli cultured from their stool. The highest rates of ESBL positivity were associated with travel to Africa or the Indian subcontinent. Among the 31 ESBL-producing E coli isolated, 22 produced CTX-M-15, 8 produced CTX-M-14, 1 produced CTX-M-8, 12 were positive for aac(6')-Ib-cr, and 8 belonged to clone ST131.
Conclusions:
Our study confirms that foreign travel, especially to the Indian subcontinent and Africa, represents a major risk for rectal colonization with CTX-M-producing E coli and contributed to the Worldwide spread of these bacteria.
Insights
Foreign travel significantly increases the risk of acquiring CTX-M-producing Escherichia coli (E. coli) infections. Travelers, especially those visiting Africa or the Indian subcontinent, are more likely to carry these antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Foreign travel is a known risk factor for acquiring infections caused by CTX-M-producing Escherichia coli (E. coli).
- CTX-M enzymes confer resistance to cefotaxime, a key antibiotic.
Purpose of the Study:
- To determine the prevalence of extended-spectrum beta-lactamase (ESBL)-producing E. coli in travelers compared to non-travelers.
- To identify specific travel destinations associated with higher rates of ESBL-producing E. coli.
Main Methods:
- Stool samples from travelers and non-travelers were cultured on selective media for ESBL-producing E. coli.
- Molecular techniques, including PCR and sequencing, were used for characterization of resistance genes (blaCTX-Ms, blaTEMs, blaSHVs), quinolone resistance determinants, and E. coli strains (O25-ST131, phylogenetic groups).
- Pulsed-field gel electrophoresis (PFGE) and multilocus sequencing typing were employed for strain typing.
Main Results:
- Out of 226 individuals, 31 (14%) had ESBL-producing E. coli; 195 (86%) were negative.
- Travelers were 5.2 times more likely to have ESBL-producing E. coli than non-travelers.
- Highest positivity rates were linked to travel to Africa and the Indian subcontinent. CTX-M-15 was the most common CTX-M type, and clone ST131 was prevalent.
Conclusions:
- Foreign travel, particularly to Africa and the Indian subcontinent, is a significant risk factor for rectal colonization with CTX-M-producing E. coli.
- This highlights the role of international travel in the global dissemination of these multidrug-resistant bacteria.
Related Concept Videos
Bacterial Gastroenteritis
Colonisation of Pathogens
Cholera
Amebiasis
